Vivos Receives FDA Clearance

We're excited to share a significant milestone in the world of airway health: Vivos Therapeutics has received the first-ever FDA 510(k) clearance for an oral device to treat severe obstructive sleep apnea (OSA) in adults. This news marks a turning point in how we approach one of the most underdiagnosed—and potentially dangerous—health conditions today.

At Epic Dentistry, we’ve long understood that airway health is foundational to whole-body wellness. That’s why we’ve integrated Vivos into our treatment options for patients with mild to moderate OSA, jaw development issues, and TMJ disorders. Now, with this FDA clearance, we’re thrilled that even more patients—including those with severe sleep apnea—may be eligible for a less invasive, non-CPAP solution.

Vivos devices are designed not just to manage symptoms, but to address the root causes of airway obstruction by improving upper jaw development and nasal breathing. It’s a personalized, non-surgical treatment approach that aligns with our commitment to biomimetic, airway-informed care.



If you or a loved one has been diagnosed with sleep apnea—or suspect you might be suffering from it—now is the time to take a closer look at your options. We’re here to guide you through the next steps with expertise, compassion, and innovative tools that support lasting health.